Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'selective serotonin reuptake inhibitor' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 108 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Buchsbaum, MS; Hollander, E; Haznedar, MM; Tang, C; Spiegel-Cohen, J; Wei, TC; Solimando, A; Buchsbaum, BR; Robins, D; Bienstock, C; Cartwright, C; Mosovich, S
      Effect of fluoxetine on regional cerebral metabolism in autistic spectrum disorders: a pilot study

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    2. Pollak, PT; Mukherjee, SD; Fraser, AD
      Sertraline-induced hypoglycemia

      ANNALS OF PHARMACOTHERAPY
    3. Smith, DF; Bender, D; Marthi, K; Cumming, P; Hansen, SB; Peters, D; Nielsen, EO; Scheel-Kruger, J; Gjedde, A
      Synthesis and evaluation of racemic [C-11]NS2456 and its enantiomers as selective serotonin reuptake radiotracers for PET

      NUCLEAR MEDICINE AND BIOLOGY
    4. Kasper, S; Resinger, E
      Panic disorder: the place of benzodiazepines and selective serotonin reuptake inhibitors

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    5. Jacobs, ES; Dickstein, DP; Liebelt, EL
      Novel psychotropic medications in children: New toxicities to master

      PEDIATRIC EMERGENCY CARE
    6. Shores, MM; Pascualy, M; Lewis, NL; Flatness, D; Veith, RC
      Short-term sertraline treatment suppresses sympathetic nervous system activity in healthy human subjects

      PSYCHONEUROENDOCRINOLOGY
    7. Yamada, M; Yamada, M; Yamazaki, S; Takahashi, K; Nara, K; Ozawa, H; Yamada, S; Kiuchi, Y; Oguchi, K; Kamijima, K; Higuchi, T; Momose, K
      Induction of cysteine string protein after chronic antidepressant treatment in rat frontal cortex

      NEUROSCIENCE LETTERS
    8. Blakely, RD
      Physiological genomics of antidepressant targets: Keeping the periphery inmind

      JOURNAL OF NEUROSCIENCE
    9. Ogawa, K; Sasaki, H; Kishi, Y; Yamasaki, H; Okamoto, K; Yamamoto, N; Hanabusa, T; Nakao, T; Nishi, M; Nanjo, K
      A suspected case of proximal diabetic neuropathy predominantly presenting with scapulohumeral muscle weakness and deep aching pain

      DIABETES RESEARCH AND CLINICAL PRACTICE
    10. Pezzella, G; Moslinger-Gehmayr, R; Contu, A
      Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline

      BREAST CANCER RESEARCH AND TREATMENT
    11. Asnis, GM; Hameedi, FA; Goddard, AW; Potkin, SG; Black, D; Jameel, M; Desagani, K; Woods, SW
      Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients

      PSYCHIATRY RESEARCH
    12. Greil, W; Horvath, A; Sassim, N; Erazo, N; Grohmann, R
      Disinhibition of libido: an adverse effect of SSRI?

      JOURNAL OF AFFECTIVE DISORDERS
    13. Eltayb, A; Svensson, TH; Ahlenius, S
      Catalepsy induced by the 5-HT1A receptor antagonist WAY 100635 in rats pretreated with the selective serotonin reuptake inhibitor citalopram

      EUROPEAN JOURNAL OF PHARMACOLOGY
    14. Angulo, J; Peiro, C; Sanchez-Ferrer, CF; Gabancho, S; Cuevas, P; Gupta, S; de Tejada, IS
      Differential effects of serotonin reuptake inhibitors on erectile responses, NO-production, and neuronal NO synthase expression in rat corpus cavernosum tissue

      BRITISH JOURNAL OF PHARMACOLOGY
    15. Pariante, CM; Makoff, A; Lovestone, S; Feroli, S; Heyden, A; Miller, AH; Kerwin, RW
      Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters

      BRITISH JOURNAL OF PHARMACOLOGY
    16. Singh, VP; Jain, NK; Kulkarni, SK
      On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor

      BRAIN RESEARCH
    17. Huber, R; Panksepp, JB; Yue, Z; Delago, A; Moore, P
      Dynamic interactions of behavior and amine neurochemistry in acquisition and maintenance of social rank in crayfish

      BRAIN BEHAVIOR AND EVOLUTION
    18. Stein, DJ; Stein, MB; Goodwin, W; Kumar, R; Hunter, B
      The selective serotonin reuptake in more generalized and in less inhibitorparoxetine is effective generalized social anxiety disorder

      PSYCHOPHARMACOLOGY
    19. Oerther, S; Ahlenius, S
      Involvement of 5-HT1A and 5-HT1B receptors for citalopram-induced hypothermia in the rat

      PSYCHOPHARMACOLOGY
    20. Davidson, JRT
      Social anxiety disorder under scrutiny

      DEPRESSION AND ANXIETY
    21. Millan, MJ; Gobert, A; Rivet, JM; Adhumeau-Auclair, A; Cussac, D; Newman-Tancredi, A; Dekeyne, A; Nicolas, JP; Lejeune, F
      Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha(2)-adrenergic and serotonin(2C) receptors: a comparison with citalopram

      EUROPEAN JOURNAL OF NEUROSCIENCE
    22. Catalano, MC; Catalano, G; Kanfer, SN; Toner, LC; Stock, SL; Taylor, WD
      The effect of sertraline on routine blood chemistry values

      CLINICAL NEUROPHARMACOLOGY
    23. Schlosser, R; Wetzel, H; Dorr, H; Rossbach, W; Hiemke, C; Benkert, O
      Effects of subchronic paroxetine administration on night-time endocrinological profiles in healthy male volunteers

      PSYCHONEUROENDOCRINOLOGY
    24. Oberndorfer, S; Saletu-Zyhlarz, G; Saletu, B
      Effects of selective serotonin reuptake inhibitors on objective and subjective sleep quality

      NEUROPSYCHOBIOLOGY
    25. Nolen, WA; Bleomkolk, D
      Treatment of bipolar depression, a review of the literature and a suggestion for an algorithm

      NEUROPSYCHOBIOLOGY
    26. Van der Linden, G; Van Heerden, B; Warwick, J; Wessels, C; Van Kradenburg, J; Zungu-Dirwayi, N; Stein, DJ
      Functional brain imaging and pharmacotherapy in social phobia: Single photon emission computed tomography before and after treatment with the selective serotonin reuptake inhibitor citalopram

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    27. Millan, MJ; Lejeune, F; Gobert, A
      Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents

      JOURNAL OF PSYCHOPHARMACOLOGY
    28. Hidalgo, RB; Davidson, JRT
      Selective serotonin reuptake inhibitors in post-traumatic stress disorder

      JOURNAL OF PSYCHOPHARMACOLOGY
    29. Stein, DJ; Stahl, S
      Serotonin and anxiety: current models

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    30. Moller, SE; Larsen, F; Pitsiu, M; Rolan, PE
      Effect of citalopram on plasma levels of oral theophylline

      CLINICAL THERAPEUTICS
    31. Kashyap, AS
      Phaeochromocytoma unearthed by fluoxetine

      POSTGRADUATE MEDICAL JOURNAL
    32. Egashira, T; Takayama, F; Yamanaka, Y; Takada, K; Takeda, H; Matsumiya, T
      Day/night variation of 5-hydroxyindole acetic acid concentration in rat cerebrospinal fluid after acute and long-term administration of a selective serotonin reuptake inhibitor, fluvoxamine

      JAPANESE JOURNAL OF PHARMACOLOGY
    33. Veenstra-VanderWeele, J; Anderson, GM; Cook, EH
      Pharmacogenetics and the serotonin system: initial studies and future directions

      EUROPEAN JOURNAL OF PHARMACOLOGY
    34. Subhan, F; Deslandes, PN; Pache, DM; Sewell, RDE
      Do antidepressants affect motivation in conditioned place preference?

      EUROPEAN JOURNAL OF PHARMACOLOGY
    35. Hatanaka, K; Yatsugi, S; Yamaguchi, T
      Effect of acute treatment with YM992 on extracellular serotonin levels in the rat frontal cortex

      EUROPEAN JOURNAL OF PHARMACOLOGY
    36. Arborelius, L; Linner, L; Wallsten, C; Ahlenius, S; Svensson, TH
      Partial 5-HT1A receptor agonist properties of (-)pindolol in combination with citalopram on serotonergic dorsal raphe cell firing in vivo

      PSYCHOPHARMACOLOGY
    37. Josey, ES; Tackett, RL
      St. John's wort: a new alternative for depression?

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    38. Isaac, M
      Where are we going with SSRIs?

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    39. Rogde, S; Hilberg, T; Teige, B
      Fatal combined intoxication with new antidepressants. Human cases and an experimental study of postmortem moclobemide redistribution

      FORENSIC SCIENCE INTERNATIONAL
    40. Akagawa, Y; Masuda, Y; Maruyama, A; Shimizu, T; Hishikawa, Y
      Effects of repeated selective serotonin reuptake inhibitor paroxetine treatments on mouse forced swimming

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    41. Moritz, F; Goulle, JP; Girault, C; Clarot, F; Droy, JM; Muller, JM
      Toxicological analysis in agitated patients

      INTENSIVE CARE MEDICINE
    42. Acton, PD; Kung, MP; Mu, M; Plossl, K; Hou, C; Siciliano, M; Oya, S; Kung, HF
      Single-photon emission tomography imaging of serotonin transporters in thenon-human primate brain with the selective radioligand [I-123]IDAM

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    43. Xu, ZH; Wang, W; Zhao, XJ; Huang, SL; Zhu, B; He, N; Shu, Y; Liu, ZQ; Zhou, HH
      Evidence for involvement of polymorphic CYP2C 19 and 2C9 in the N-demethylation of sertraline in human liver microsomes

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    44. Stein, DJ; Van Heerden, B; Wessels, CJ; Van Kradenburg, J; Warwick, J; Wasserman, HJ
      Single photon emission computed tomography of the brain with Tc-99m HMPAO during sumatriptan challenge in obsessive-compulsive disorder: Investigating the functional role of the serotonin auto-receptor

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    45. Poyurovsky, M; Isakov, V; Hromnikov, S; Modai, I; Rauchberger, B; Schneidman, M; Weizman, A
      Fluvoxamine treatment of obsessive-compulsive symptoms in schizophrenic patients: an add-on open study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    46. Thorell, LH; Kjellman, B; Arned, M; Lindwall-Sundel, K; Walinder, J; Wetterberg, L
      Light treatment of seasonal affective disorder in combination with citalopram or placebo with 1-year follow-up

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    47. Mendlewicz, J
      Predicting response: serotonin reuptake inhibition

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    48. Voirol, P; Rubin, C; Bryois, C; Kosel, M; Buclin, T; Baumann, P
      Pharmacokinetic consequences of a citalopram treatment discontinuation

      THERAPEUTIC DRUG MONITORING
    49. Pozzi, L; Invernizzi, R; Garavaglia, C; Samanin, R
      Fluoxetine increases extracellular dopamine in the prefrontal cortex by a mechanism not dependent on serotonin: A comparison with citalopram

      JOURNAL OF NEUROCHEMISTRY
    50. Landy, S; McGinnis, J; Curlin, D; Laizure, SC
      Selective serotonin reuptake inhibitors for migraine prophylaxis

      HEADACHE
    51. Yamada, J; Sugimoto, Y; Inoue, K
      Selective serotonin reuptake inhibitors fluoxetine and fluvoxamine induce hyperglycemia by different mechanisms

      EUROPEAN JOURNAL OF PHARMACOLOGY
    52. Skaer, TL; Robison, LM; Sclar, DA; Dickson, WM; Kozma, GM; Reeder, CE
      Use of antidepressant pharmacotherapy within the first year after diagnosis of diabetes mellitus: A study of a medicaid population

      CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    53. Szabo, ST; de Montigny, C; Blier, P
      Modulation of noradrenergic neuronal firing by selective serotonin reuptake blockers

      BRITISH JOURNAL OF PHARMACOLOGY
    54. Rochat, B; Baumann, P; Audus, KL
      Transport mechanisms for the antidepressant citalopram in brain microvessel endothelium

      BRAIN RESEARCH
    55. de Gandarias, JM; Echevarria, E; Acebes, I; Abecia, LC; Casis, O; Casis, L
      Effects of fluoxetine administration on mu-opoid receptor immunostaining in the rat forebrain

      BRAIN RESEARCH
    56. von Moltke, LL; Greenblatt, DJ; Grassi, JM; Granda, BW; Venkatakrishnan, K; Duan, SX; Fogelman, SM; Harmatz, JS; Shader, RI
      Citalopram and desmethylcitalopram in vitro: Human cytochromes mediating transformation, and cytochrome inhibitory effects

      BIOLOGICAL PSYCHIATRY
    57. Wolff, MC; Leander, JD
      The discriminative stimulus properties of LY233708, a selective serotonin reuptake inhibitor, in the pigeon

      PSYCHOPHARMACOLOGY
    58. LAINECESSAC P; SHOAAY I; GARRE JB; GLAUD V; TURCANT A; ALLAIN P
      STUDY OF HEMOSTASIS IN DEPRESSIVE PATIENTS TREATED WITH FLUOXETINE

      Pharmacoepidemiology and drug safety
    59. GILLMAN PK
      SEROTONIN SYNDROME - HISTORY AND RISK

      Fundamental and clinical pharmacology
    60. Callaway, JC; Grob, CS
      Ayahuasca preparations and serotonin reuptake inhibitors: A potential combination for severe adverse interactions

      JOURNAL OF PSYCHOACTIVE DRUGS
    61. TOME MB; ISAAC MT
      ONE-YEAR REAL-WORLD PROSPECTIVE FOLLOW-UP-STUDY OF A MAJOR DEPRESSIVEEPISODE OF PATIENTS TREATED WITH PAROXETINE AND PINDOLOL OR PAROXETINE FOR 6 WEEKS

      International clinical psychopharmacology
    62. TOME MB; ISAAC MT
      COST-EFFECTIVENESS STUDY OF A YEAR FOLLOW-UP OF SELECTIVE SEROTONIN REUPTAKE INHIBITOR(SSRI) AND AUGMENTOR COMBINATION COMPARED WITH SSRI AND PLACEBO

      International clinical psychopharmacology
    63. SCLAR DA; ROBISON LM; SKAER TL; GALIN RS
      TRENDS IN THE PRESCRIBING OF ANTIDEPRESSANT PHARMACOTHERAPY - OFFICE-BASED VISITS, 1990-1995

      Clinical therapeutics
    64. Sclar, DA; Robison, LM; Skaer, TL; Galin, RS
      What factors influence the prescribing of antidepressant pharmacotherapy? An assessment of national office-based encounters

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE
    65. FAHERTY CJ; HARKIN AJ; LEONARD BE
      THE FUNCTIONAL SENSITIZATION OF SIGMA-RECEPTORS FOLLOWING CHRONIC SELECTIVE SEROTONIN REUPTAKE INHIBITOR TREATMENT

      European journal of pharmacology
    66. WOLFF MC; LEANDER JD
      SELECTIVE SEROTONIN REUPTAKE INHIBITORS POTENTIATE 8-OH-DPAT-INDUCED STIMULUS-CONTROL IN THE PIGEON

      European journal of pharmacology
    67. HUGHES ZA; STANFORD SC
      EVIDENCE FROM MICRODIALYSIS AND SYNAPTOSOMAL STUDIES OF RAT CORTEX FOR NORADRENALINE UPTAKE SITES WITH DIFFERENT SENSITIVITIES TO SSRIS

      British Journal of Pharmacology
    68. REDROBE JP; BOURIN M
      DOSE-DEPENDENT INFLUENCE OF BUSPIRONE ON THE ACTIVITIES OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN THE MOUSE FORCED SWIMMING TEST

      Psychopharmacology
    69. DAVIES PH
      DRUG-RELATED HYPERPROLACTINEMIA

      Adverse drug reactions and toxicological reviews
    70. STEIN DJ; BOUWER C; MAUD CM
      USE OF THE SELECTIVE SEROTONIN REUPTAKE INHIBITOR CITALOPRAM IN TREATMENT OF TRICHOTILLOMANIA

      European archives of psychiatry and clinical neuroscience
    71. FOURNIER JP; LANE RM; CHOUINARD G; WATSON DB; AMIN M; REMICK RA; THORPE LU
      A DOUBLE-BLIND COMPARISON OF SERTRALINE AND IMIPRAMINE IN OUTPATIENTSWITH MAJOR DEPRESSION - ACUTE (8 WEEKS) AND CONTINUATION (16 WEEKS) TREATMENT

      Human psychopharmacology
    72. LECRUBIER Y
      MILNACIPRAN - THE CLINICAL PROPERTIES OF A SELECTIVE SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR (SNRI)

      Human psychopharmacology
    73. KASPER S
      THE PLACE OF MILNACIPRAN IN THE TREATMENT OF DEPRESSION

      Human psychopharmacology
    74. SCHMIDER J; GREENBLATT DJ; VONMOLTKE LL; KARSOV D; SHADER RI
      INHIBITION OF CYP2C9 BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN-VITRO - STUDIES OF PHENYTOIN P-HYDROXYLATION

      British journal of clinical pharmacology
    75. EKSELIUS L; VONKNORRING L; EBERHARD G
      A DOUBLE-BLIND MULTICENTER TRIAL COMPARING SERTRALINE AND CITALOPRAM IN PATIENTS WITH MAJOR DEPRESSION TREATED IN GENERAL-PRACTICE

      International clinical psychopharmacology
    76. BERK M; ACTON M
      CITALOPRAM-ASSOCIATED CLITORAL PRIAPISM - A CASE SERIES

      International clinical psychopharmacology
    77. AMSTERDAM JD; GARCIAESPANA F; GOODMAN D; HOOPER M; HORNIGROHAN M
      BREAST ENLARGEMENT DURING CHRONIC ANTIDEPRESSANT THERAPY

      Journal of affective disorders
    78. SILLS TL; FLETCHER PJ
      FLUOXETINE ATTENUATES MORPHINE-INDUCED LOCOMOTION AND BLOCKS MORPHINE-SENSITIZATION

      European journal of pharmacology
    79. SPROUSE J; CLARKE T; REYNOLDS L; HEYM J; ROLLEMA H
      COMPARISON OF THE EFFECTS OF SERTRALINE AND ITS METABOLITE DESMETHYLSERTRALINE ON BLOCKADE OF CENTRAL 5-HT REUPTAKE IN-VIVO

      Neuropsychopharmacology
    80. WAGNER W; HOUSER V; WONG LF
      THE SAFETY PROFILE OF FLUVOXAMINE IN ELDERLY PATIENTS

      Human psychopharmacology
    81. MARTENSSON B; ABERGWISTEDT A
      THE USE OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS AMONG SWEDISH PSYCHIATRISTS - RESULTS OF A QUESTIONNAIRE

      Nordic journal of psychiatry
    82. CHOUINARD G; BELANGER MC; BEAUCLAIR L; SULTAN S; MURPHY BEP
      POTENTIATION OF FLUOXETINE BY AMINOGLUTETHIMIDE, AN ADRENAL-STEROID SUPPRESSANT, IN OBSESSIVE-COMPULSIVE DISORDER RESISTANT TO SSRIS - A CASE-REPORT

      Progress in neuro-psychopharmacology & biological psychiatry
    83. DINAN TG
      SEROTONIN - CURRENT UNDERSTANDING AND THE WAY FORWARD

      International clinical psychopharmacology
    84. NECKELMANN D; BJORVATN B; BJORKUM AA; URSIN R
      CITALOPRAM - DIFFERENTIAL SLEEP WAKE AND EEG POWER SPECTRUM EFFECTS AFTER SINGLE-DOSE AND CHRONIC ADMINISTRATION/

      Behavioural brain research
    85. WESTENBERG HGM
      DEVELOPMENTS IN THE DRUG-TREATMENT OF PANIC DISORDER - WHAT IS THE PLACE OF THE SELECTIVE SEROTONIN REUPTAKE INHIBITORS

      Journal of affective disorders
    86. PERRY PJ
      PHARMACOTHERAPY FOR MAJOR DEPRESSION WITH MELANCHOLIC FEATURES - RELATIVE EFFICACY OF TRICYCLIC VERSUS SELECTIVE SEROTONIN REUPTAKE INHIBITOR ANTIDEPRESSANTS

      Journal of affective disorders
    87. FORDER J; KAVANAGH S; FENYO A
      A COMPARISON OF THE COST-EFFECTIVENESS OF SERTRALINE VERSUS TRICYCLICANTIDEPRESSANTS IN PRIMARY-CARE

      Journal of affective disorders
    88. FRANCHINI L; ZANARDI R; GASPERINI M; PEREZ J; SMERALDI E
      FLUVOXAMINE AND LITHIUM IN LONG-TERM TREATMENT OF UNIPOLAR SUBJECTS WITH HIGH RECURRENCE RATE

      Journal of affective disorders
    89. HATANAKA K; NOMURA T; HIDAKA K; TAKEUCHI H; YATSUGI S; FUJII M; YAMAGUCHI T
      BIOCHEMICAL PROFILE OF YM992, A NOVEL SELECTIVE SEROTONIN REUPTAKE INHIBITOR WITH 5-HT2A RECEPTOR ANTAGONISTIC ACTIVITY

      Neuropharmacology
    90. FIORELLA D; HELSLEY S; RABIN RA; WINTER JC
      POTENTIATION OF LSD-INDUCED STIMULUS-CONTROL BY FLUOXETINE IN THE RAT

      Life sciences
    91. ROLLEMA H; CLARKE T; SPROUSE JS; SCHULZ DW
      COMBINED ADMINISTRATION OF A 5-HYDROXYTRYPTAMINE (5-HT)(1D) ANTAGONIST AND A 5-HT REUPTAKE INHIBITOR SYNERGISTICALLY INCREASES 5-HT RELEASEIN GUINEA-PIG HYPOTHALAMUS IN-VIVO

      Journal of neurochemistry
    92. HUGHES ZA; STANFORD SC
      INCREASED NORADRENALINE EFFLUX INDUCED BY LOCAL INFUSION OF FLUOXETINE IN THE RAT FRONTAL-CORTEX

      European journal of pharmacology
    93. INOUE T; HASHIMOTO S; TSUCHIYA K; IZUMI T; OHMORI T; KOYAMA T
      EFFECT OF CITALOPRAM, A SELECTIVE SEROTONIN REUPTAKE INHIBITOR, ON THE ACQUISITION OF CONDITIONED FREEZING

      European journal of pharmacology
    94. HJORTH S
      (-)-PINDOLOL, BUT NOT BUSPIRONE, POTENTIATES THE CITALOPRAM-INDUCED RISE IN EXTRACELLULAR 5-HYDROXYTRYPTAMINE

      European journal of pharmacology
    95. PETERSEN B; MORK A
      CHRONIC TREATMENT WITH CITALOPRAM INDUCES NORADRENALINE RECEPTOR HYPOACTIVITY - A MICRODIALYSIS STUDY

      European journal of pharmacology
    96. SANZFUENTENEBRO FJ; HUIDOBRO A; TEJADASRIVAS A
      RESTLESS LEGS SYNDROME AND PAROXETINE

      Acta psychiatrica Scandinavica
    97. KARLSSON I
      PHARMACOLOGICAL TREATMENT OF NONCOGNITIVE SYMPTOMS OF DEMENTIA

      Acta neurologica Scandinavica
    98. VANMOFFAERT M; BARTHOLOME F; COSYNS P; DENAYER AR; MERTENS C
      A CONTROLLED COMPARISON OF SERTRALINE AND FLUOXETINE IN ACUTE AND CONTINUATION TREATMENT OF MAJOR DEPRESSION

      Human psychopharmacology
    99. RAVINDRAN AV; GRIFFITHS J; MERALI Z; ANISMAN H
      LYMPHOCYTE SUBSETS ASSOCIATED WITH MAJOR DEPRESSION AND DYSTHYMIA - MODIFICATION BY ANTIDEPRESSANT TREATMENT

      Psychosomatic medicine
    100. ICHIMARU Y; EGAWA T; SAWA A
      5-HT1A-RECEPTOR SUBTYPE MEDIATES THE EFFECT OF FLUVOXAMINE, A SELECTIVE SEROTONIN REUPTAKE INHIBITOR, ON MARBLE-BURYING BEHAVIOR IN MICE

      Japanese Journal of Pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/02/20 alle ore 14:04:43